S
Sunny A. Linnebur
Researcher at University of Montana
Publications - 81
Citations - 1831
Sunny A. Linnebur is an academic researcher from University of Montana. The author has contributed to research in topics: Geriatrics & Population. The author has an hindex of 21, co-authored 79 publications receiving 1514 citations. Previous affiliations of Sunny A. Linnebur include University of Colorado Boulder & Anschutz Medical Campus.
Papers
More filters
Journal ArticleDOI
Inappropriate prescribing in the hospitalized elderly patient: Defining the problem, evaluation tools, and possible solutions
TL;DR: Critical issues surrounding PIM prescribing in the acute care setting such as risk factors, screening tools, and potential strategies to minimize this significant public health problem are highlighted.
Journal ArticleDOI
Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence:
TL;DR: Older adults should be periodically evaluated for the need for continued use of PPI therapy given the number of potential adverse effects associated with long-term use.
Journal ArticleDOI
Patient-level medication regimen complexity across populations with chronic disease
Anne M. Libby,Anne M. Libby,Douglas N. Fish,Patrick Hosokawa,Sunny A. Linnebur,Kelli R. Metz,Kavita V. Nair,Joseph J. Saseen,Joseph P. Vande Griend,Sara P. Vu,Jan D. Hirsch +10 more
TL;DR: The quantitative Medication Regimen Complexity Index (MRCI) was implemented at the patient level in defined populations with chronic disease (geriatric depression, HIV, diabetes mellitus, and hypertension).
Journal ArticleDOI
High-Dose Monthly Vitamin D for Prevention of Acute Respiratory Infection in Older Long-Term Care Residents: A Randomized Clinical Trial.
Adit A. Ginde,Patrick J. Blatchford,Patrick J. Blatchford,Keith Breese,Lida Zarrabi,Sunny A. Linnebur,Sunny A. Linnebur,Jeffrey I. Wallace,Robert S. Schwartz,Robert S. Schwartz +9 more
TL;DR: To determine the efficacy and safety of high‐dose vitamin D supplementation for prevention of acute respiratory infection (ARI) in older long‐term care residents, a large number of residents are enrolled in long-term care.
Journal ArticleDOI
FDA Drug Safety Communications: A Narrative Review and Clinical Considerations for Older Adults
TL;DR: FDA drug safety communications incorporate complex methodologies that investigate the risks (and relative benefits) of medication therapy and need to be aware of the most current evidence behind these drug risks to effectively communicate with and care for their patients.